The University of Chicago Header Logo

Connection

Jonathan Rich to Humans

Back to Details
This is a "connection" page, showing publications Jonathan Rich has written about Humans.
Jonathan Rich
Connection Strength
0.702
Humans
  1. Epidemiology of Heart Failure and the Discovery of the Cardioprotective Effects of SGLT2 Inhibitors. JACC Heart Fail. 2024 Jun; 12(6S):S1-S3.
    View in: PubMed
    Score: 0.030
  2. Hyponatremia Is a Powerful Predictor of Poor Prognosis in Left Ventricular Assist Device Patients. ASAIO J. 2022 12 01; 68(12):1475-1482.
    View in: PubMed
    Score: 0.027
  3. Risk of Renal Dysfunction Following Heart Transplantation in Patients Bridged with a Left Ventricular Assist Device. ASAIO J. 2022 05 01; 68(5):646-653.
    View in: PubMed
    Score: 0.025
  4. Obesity and Outcomes Following Cardiogenic Shock Requiring Acute Mechanical Circulatory Support. Circ Heart Fail. 2021 03; 14(3):e007937.
    View in: PubMed
    Score: 0.024
  5. The Inherent Fallacy of Predicting RV Failure Following Left Ventricular Assist Device Implantation. J Card Fail. 2019 08; 25(8):629-630.
    View in: PubMed
    Score: 0.022
  6. Meta-Analysis Global Group in Chronic (MAGGIC) Heart Failure Risk Score: Validation of a Simple Tool for the Prediction of Morbidity and Mortality in Heart Failure With Preserved Ejection Fraction. J Am Heart Assoc. 2018 10 16; 7(20):e009594.
    View in: PubMed
    Score: 0.021
  7. Is Anticoagulation Beneficial in Pulmonary Arterial Hypertension? Circ Cardiovasc Qual Outcomes. 2018 09; 11(9):e004757.
    View in: PubMed
    Score: 0.020
  8. HVAD Flow Waveform Morphologies: Theoretical Foundation and Implications for Clinical Practice. ASAIO J. 2017 Sep-Oct; 63(5):526-535.
    View in: PubMed
    Score: 0.019
  9. The incidence, risk factors, and outcomes associated with late right-sided heart failure in patients supported with an axial-flow left ventricular assist device. J Heart Lung Transplant. 2017 01; 36(1):50-58.
    View in: PubMed
    Score: 0.018
  10. Comparison of metolazone versus chlorothiazide in acute decompensated heart failure with diuretic resistance. Cardiovasc Ther. 2015 Apr; 33(2):42-9.
    View in: PubMed
    Score: 0.016
  11. Novel technologies and devices for monitoring and treating pulmonary arterial hypertension. Can J Cardiol. 2015 Apr; 31(4):478-88.
    View in: PubMed
    Score: 0.016
  12. MY APPROACH to the patient with pulmonary embolism. Trends Cardiovasc Med. 2015 May; 25(4):374-5.
    View in: PubMed
    Score: 0.016
  13. Clinical diagnosis of pulmonary hypertension. Circulation. 2014 Nov 11; 130(20):1820-30.
    View in: PubMed
    Score: 0.016
  14. Counterpoint: can Doppler echocardiography estimates of pulmonary artery systolic pressures be relied upon to accurately make the diagnosis of pulmonary hypertension? No. Chest. 2013 Jun; 143(6):1536-1539.
    View in: PubMed
    Score: 0.014
  15. Rebuttal from Dr Rich. Chest. 2013 Jun; 143(6):1540-1541.
    View in: PubMed
    Score: 0.014
  16. Noninvasive cardiac output measurements in patients with pulmonary hypertension. Eur Respir J. 2013 Jul; 42(1):125-33.
    View in: PubMed
    Score: 0.014
  17. Right ventricular failure in patients with left ventricular assist devices. Cardiol Clin. 2012 May; 30(2):291-302.
    View in: PubMed
    Score: 0.013
  18. Faces of right ventricular failure. Cardiol Clin. 2012 May; 30(2):xi.
    View in: PubMed
    Score: 0.013
  19. QTc prolongation is associated with impaired right ventricular function and predicts mortality in pulmonary hypertension. Int J Cardiol. 2013 Aug 10; 167(3):669-76.
    View in: PubMed
    Score: 0.013
  20. The effect of diluent pH on bloodstream infection rates in patients receiving IV treprostinil for pulmonary arterial hypertension. Chest. 2012 Jan; 141(1):36-42.
    View in: PubMed
    Score: 0.012
  21. Prior aspirin use and outcomes in acute coronary syndromes. J Am Coll Cardiol. 2010 Oct 19; 56(17):1376-85.
    View in: PubMed
    Score: 0.012
  22. Inaccuracy of Doppler echocardiographic estimates of pulmonary artery pressures in patients with pulmonary hypertension: implications for clinical practice. Chest. 2011 May; 139(5):988-993.
    View in: PubMed
    Score: 0.012
  23. Right-ventricular function by nuclear cardiology. Curr Opin Cardiol. 2010 Sep; 25(5):445-50.
    View in: PubMed
    Score: 0.012
  24. Comparison of high risk stress myocardial perfusion imaging findings in men with rapid versus prolonged recovery of ST-segment depression after exercise stress testing. Am J Cardiol. 2010 May 15; 105(10):1361-4.
    View in: PubMed
    Score: 0.011
  25. The search for an oral prostanoid to treat pulmonary arterial hypertension continues. Are we getting any closer? Int J Clin Pract Suppl. 2009 Mar; (161):17-8.
    View in: PubMed
    Score: 0.011
  26. New antiplatelet therapies for acute coronary syndromes. Curr Cardiol Rep. 2007 Jul; 9(4):303-11.
    View in: PubMed
    Score: 0.009
  27. Heparin resistance in acute coronary syndromes. J Thromb Thrombolysis. 2007 Apr; 23(2):93-100.
    View in: PubMed
    Score: 0.009
  28. Considerations in the Diagnosis and Management of Pulmonary Hypertension Associated With Left Heart Disease. JACC Heart Fail. 2024 Aug; 12(8):1328-1342.
    View in: PubMed
    Score: 0.008
  29. Summary and Panel Discussion. JACC Heart Fail. 2024 Jun; 12(6S):S10-S11.
    View in: PubMed
    Score: 0.008
  30. Efficient measurement of multiple ventricular assist device patient-reported outcomes: Creation of a 20-item profile from the MCS A-QOL study. J Heart Lung Transplant. 2024 Aug; 43(8):1308-1317.
    View in: PubMed
    Score: 0.008
  31. Novel measures to assess ventricular assist device patient-reported outcomes: Findings from the MCS A-QOL study. J Heart Lung Transplant. 2024 01; 43(1):36-50.
    View in: PubMed
    Score: 0.007
  32. Global best practices consensus: Long-term management of patients with hybrid centrifugal flow left ventricular assist device support. J Thorac Cardiovasc Surg. 2022 10; 164(4):1120-1137.e2.
    View in: PubMed
    Score: 0.007
  33. Time Spent Engaging in Health Care Among Patients With Left Ventricular Assist Devices. JACC Heart Fail. 2022 05; 10(5):321-332.
    View in: PubMed
    Score: 0.007
  34. Colonization with Multidrug-resistant Organisms in Patients with Ventricular Assist Devices. ASAIO J. 2022 08 01; 68(8):1048-1053.
    View in: PubMed
    Score: 0.006
  35. A Power Tracking Algorithm for Early Detection of Centrifugal Flow Pump Thrombosis. ASAIO J. 2021 09 01; 67(9):1018-1025.
    View in: PubMed
    Score: 0.006
  36. Levosimendan Improves Hemodynamics and Exercise Tolerance in PH-HFpEF: Results of the Randomized Placebo-Controlled HELP Trial. JACC Heart Fail. 2021 05; 9(5):360-370.
    View in: PubMed
    Score: 0.006
  37. Prothrombin Complex Concentrate for Emergent Reversal of Intracranial Hemorrhage in Patients with Ventricular Assist Devices. Neurocrit Care. 2021 10; 35(2):506-517.
    View in: PubMed
    Score: 0.006
  38. Cardiac transplantation outcomes in patients with amyloid cardiomyopathy. Am Heart J. 2021 06; 236:13-21.
    View in: PubMed
    Score: 0.006
  39. Laboratory testing for infection with the human immunodeficiency virus: established and novel approaches. Am J Med. 2000 Nov; 109(7):568-76.
    View in: PubMed
    Score: 0.006
  40. Association of cigarette smoking and adverse events in left ventricular assist device patients. Int J Artif Organs. 2021 Mar; 44(3):181-187.
    View in: PubMed
    Score: 0.006
  41. Prognostic Value of Myocardial Extracellular Volume Fraction and T2-mapping in Heart Transplant Patients. JACC Cardiovasc Imaging. 2020 07; 13(7):1521-1530.
    View in: PubMed
    Score: 0.006
  42. Evaluating Biventricular Myocardial Velocity and Interventricular Dyssynchrony in Adult Patients During the First Year After Heart Transplantation. J Magn Reson Imaging. 2020 09; 52(3):920-929.
    View in: PubMed
    Score: 0.006
  43. Natural History of Myocardial Late Gadolinium Enhancement Predicts Adverse Clinical Events in Heart Transplant Recipients. JACC Cardiovasc Imaging. 2019 10; 12(10):2092-2094.
    View in: PubMed
    Score: 0.005
  44. LVAD with concomitant rapid deployment valve implantation - a case report. J Cardiothorac Surg. 2019 Jul 01; 14(1):126.
    View in: PubMed
    Score: 0.005
  45. Impact of Hemodynamic Ramp Test-Guided HVAD Speed and Medication Adjustments on Clinical Outcomes. Circ Heart Fail. 2019 04; 12(4):e006067.
    View in: PubMed
    Score: 0.005
  46. Use of Balloon Atrial Septostomy in Patients With Advanced Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis. Chest. 2019 07; 156(1):53-63.
    View in: PubMed
    Score: 0.005
  47. Multiparametric Cardiac Magnetic Resonance Imaging Can Detect Acute Cardiac Allograft Rejection After Heart Transplantation. JACC Cardiovasc Imaging. 2019 08; 12(8 Pt 2):1632-1641.
    View in: PubMed
    Score: 0.005
  48. Shock - Classification and Pathophysiological Principles of Therapeutics. Curr Cardiol Rev. 2019; 15(2):102-113.
    View in: PubMed
    Score: 0.005
  49. Bridge to Transplantation With Long-Term Mechanical Assist Devices in Adults With Transposition of the Great Arteries. Artif Organs. 2019 Jan; 43(1):90-96.
    View in: PubMed
    Score: 0.005
  50. Pre-Ventricular Assist Device Palliative Care Consultation: A Qualitative Analysis. J Pain Symptom Manage. 2019 01; 57(1):100-107.
    View in: PubMed
    Score: 0.005
  51. Bibliometric Analysis of the Top 100 Most Cited Articles in the First 50 Years of Heart Transplantation. Am J Cardiol. 2019 01 01; 123(1):175-186.
    View in: PubMed
    Score: 0.005
  52. Cardiac Structure-Function MRI in Patients After Heart Transplantation. J Magn Reson Imaging. 2019 03; 49(3):678-687.
    View in: PubMed
    Score: 0.005
  53. Strokes associated with left ventricular assist devices. J Card Surg. 2018 Sep; 33(9):578-583.
    View in: PubMed
    Score: 0.005
  54. Pulmonary aspergillosis and invasive disease in AIDS: review of 342 cases. Chest. 1998 Jul; 114(1):251-62.
    View in: PubMed
    Score: 0.005
  55. Cytomegalovirus infection in heart transplantation: A single center experience. Transpl Infect Dis. 2018 Aug; 20(4):e12896.
    View in: PubMed
    Score: 0.005
  56. Controversies and Challenges of Ventricular Assist Device Therapy. Am J Cardiol. 2018 05 15; 121(10):1219-1224.
    View in: PubMed
    Score: 0.005
  57. Long-Term Survival in Patients Receiving a Continuous-Flow Left Ventricular Assist Device. Ann Thorac Surg. 2018 03; 105(3):696-701.
    View in: PubMed
    Score: 0.005
  58. Prothrombin Complex Concentrate Reduces Blood Product Utilization in Heart Transplantation. Pharmacotherapy. 2017 Oct; 37(10):1215-1220.
    View in: PubMed
    Score: 0.005
  59. Thermodilution vs Estimated Fick Cardiac Output Measurement in Clinical Practice: An Analysis of Mortality From the Veterans Affairs Clinical Assessment, Reporting, and Tracking (VA CART) Program and Vanderbilt University. JAMA Cardiol. 2017 10 01; 2(10):1090-1099.
    View in: PubMed
    Score: 0.005
  60. Enhancing Insights into Pulmonary Vascular Disease through a Precision Medicine Approach. A Joint NHLBI-Cardiovascular Medical Research and Education Fund Workshop Report. Am J Respir Crit Care Med. 2017 06 15; 195(12):1661-1670.
    View in: PubMed
    Score: 0.005
  61. Invasive fungal infection after heart transplantation: A 7-year, single-center experience. Transpl Infect Dis. 2017 Feb; 19(1).
    View in: PubMed
    Score: 0.005
  62. Hypertension, Obesity, Diabetes, and Heart Failure-Free Survival: The Cardiovascular Disease Lifetime Risk Pooling Project. JACC Heart Fail. 2016 12; 4(12):911-919.
    View in: PubMed
    Score: 0.004
  63. Outpatient Use of Focused Cardiac Ultrasound to Assess the Inferior Vena Cava in Patients With Heart Failure. Am J Cardiol. 2015 Oct 15; 116(8):1224-8.
    View in: PubMed
    Score: 0.004
  64. Echocardiography and Continuous-Flow Left Ventricular Assist Devices: Evidence and Limitations. JACC Heart Fail. 2015 Jul; 3(7):554-564.
    View in: PubMed
    Score: 0.004
  65. Sharing the care of mechanical circulatory support: collaborative efforts of patients/caregivers, shared-care sites, and left ventricular assist device implanting centers. Circ Heart Fail. 2015 May; 8(3):629-35.
    View in: PubMed
    Score: 0.004
  66. Building the case for novel clinical trials in pulmonary arterial hypertension. Circ Cardiovasc Qual Outcomes. 2015 Jan; 8(1):114-23.
    View in: PubMed
    Score: 0.004
  67. Modified HeartMate II driveline externalization technique significantly decreases incidence of infection and improves long-term survival. ASAIO J. 2014 Nov-Dec; 60(6):613-6.
    View in: PubMed
    Score: 0.004
  68. Durability of De Vega tricuspid valve annuloplasty for severe tricuspid regurgitation during left ventricular assist device implantation. Ann Thorac Surg. 2014 Jul; 98(1):81-3.
    View in: PubMed
    Score: 0.004
  69. Acute kidney injury and mortality following ventricular assist device implantation. Am J Nephrol. 2014; 39(3):195-203.
    View in: PubMed
    Score: 0.004
  70. Isolated heart transplantation for familial transthyretin (TTR) V122I cardiac amyloidosis. Amyloid. 2014 Jun; 21(2):120-3.
    View in: PubMed
    Score: 0.004
  71. Echocardiographic markers of left ventricular unloading using a centrifugal-flow rotary pump. J Heart Lung Transplant. 2014 Apr; 33(4):449-50.
    View in: PubMed
    Score: 0.004
  72. Prognostic importance of pathophysiologic markers in patients with heart failure and preserved ejection fraction. Circ Heart Fail. 2014 Mar 01; 7(2):288-99.
    View in: PubMed
    Score: 0.004
  73. Transmission of human immunodeficiency virus infection presumed to have occurred via female homosexual contact. Clin Infect Dis. 1993 Dec; 17(6):1003-5.
    View in: PubMed
    Score: 0.004
  74. The emerging epidemic of heart failure with preserved ejection fraction. Curr Heart Fail Rep. 2013 Dec; 10(4):401-10.
    View in: PubMed
    Score: 0.004
  75. Treatment of left ventricular assist device thrombosis with extended catheter-directed intraventricular thrombolytic therapy. Circ Heart Fail. 2013 May; 6(3):e27-9.
    View in: PubMed
    Score: 0.004
  76. Discrete gastrointestinal mass lesions caused by cytomegalovirus in patients with AIDS: report of three cases and review. Clin Infect Dis. 1992 Oct; 15(4):609-14.
    View in: PubMed
    Score: 0.003
  77. Current practice for determining pulmonary capillary wedge pressure predisposes to serious errors in the classification of patients with pulmonary hypertension. Am Heart J. 2012 Apr; 163(4):589-94.
    View in: PubMed
    Score: 0.003
  78. Role of impaired myocardial relaxation in the production of elevated left ventricular filling pressure. Am J Physiol Heart Circ Physiol. 2005 Mar; 288(3):H1203-8.
    View in: PubMed
    Score: 0.002
  79. Elevated basic fibroblast growth factor levels in patients with pulmonary arterial hypertension. Chest. 2004 Oct; 126(4):1255-61.
    View in: PubMed
    Score: 0.002
  80. Multicenter evaluation of hepatitis C RNA levels among female injection drug users. J Infect Dis. 2001 Mar 15; 183(6):973-6.
    View in: PubMed
    Score: 0.002
  81. Autopsy verification of Encephalitozoon intestinalis (microsporidiosis) eradication following albendazole therapy. Arch Pathol Lab Med. 1996 Feb; 120(2):199-203.
    View in: PubMed
    Score: 0.001
  82. Intestinal microsporidiosis occurring in a liver transplant recipient. Transplantation. 1995 Sep 27; 60(6):617-8.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.